SalonCompass

Treatment category

Hair Removal — safety by condition

Non-laser hair removal — waxing, sugaring, threading, electrolysis, and depilation.

In short

Hair Removal covers 6 treatments, with 389 published verdicts across 300 conditions. The conditions with the most restrictions here are A high temperature (fever) and A mole that is changing.

In this family

Treatments in this category

Where it is restricted

Conditions this category is restricted for

Computed from the verdicts on the condition pages — most restricted first.

Sources

  1. EULAR (European Alliance of Associations for Rheumatology)EULAR recommendations for the management of rheumatoid arthritis (Smolen et al.)
  2. Journal of the American Academy of DermatologyCosmetic treatment in patients with autoimmune connective tissue diseases: best practices for patients with lupus erythematosus (Bonnet et al.)
  3. British Association of DermatologistsGuidelines for the management of bullous pemphigoid
  4. International Pemphigus and Pemphigoid FoundationLiving with pemphigus and pemphigoid
  5. BMC Pregnancy and ChildbirthFatal pulmonary embolism following leg massage in undiagnosed deep vein thrombosis (case report)
  6. British Heart FoundationHeart Matters — patient information, massage and complementary therapy guidance
  7. British Association of DermatologistsTinea (dermatophyte infection) management
  8. NHSAthlete's foot
  9. NHSRingworm and other fungal infections
  10. NICEClinical Knowledge Summary: fungal skin infection
  11. Primary Care Dermatology SocietyFungal skin infections
  12. British Association of DermatologistsBacterial skin infection management
  13. NHSImpetigo
  14. NHSCellulitis and erysipelas
  15. NHSMRSA
  16. NHSBoils and carbuncles
  17. NICEClinical Knowledge Summary: impetigo
  18. UKHSAUK Standards for Microbiology Investigations
  19. NHSDiarrhoea and vomiting (gastroenteritis)
  20. NHSFlu (influenza)
  21. NHSCommon cold
  22. NHSCOVID-19
  23. UKHSALiving safely with respiratory infections, including COVID-19
  24. NHSChickenpox
  25. Royal College of Obstetricians and GynaecologistsChickenpox in pregnancy
  26. UKHSAChickenpox (varicella): guidance
  27. CDCUniversal precautions for prevention of transmission of bloodborne infections
  28. NHSHIV and AIDS — how HIV is transmitted
  29. National AIDS TrustHIV guidance for hairdressers and beauty professionals
  30. StatPearls / NCBIUniversal precautions (Kopitnik & Kahwaji)
  31. UK ParliamentEquality Act 2010, Schedule 1
  32. British Association of DermatologistsHerpes zoster management
  33. NHSShingles
  34. UKHSAImmunisation against infectious disease (the Green Book), chapter 28a — Shingles (herpes zoster)
  35. NHSTuberculosis (TB)
  36. NICENG33 Tuberculosis
  37. UKHSATuberculosis: guidance, data and analysis
  38. UKHSANotifiable diseases and causative organisms: how to report
  39. NHS Scotland (Scottish Dermatology Society)Viral warts pathway
  40. NICEClinical Knowledge Summary: warts and verrucae
  41. Primary Care Dermatology SocietyWarts and verrucae — patient information leaflet
  42. American Journal of Medical Genetics Part CThe 2017 international classification of the Ehlers-Danlos syndromes (Malfait et al.)
  43. Ehlers-Danlos Support UKLiving with EDS — skin, healing and bruising
  44. NHSEhlers-Danlos syndromes
  45. The Ehlers-Danlos SocietyEDS types, skin fragility and joint hypermobility
  46. NHSBody image and self-esteem
  47. UK Obesity FederationDignity, equipment and access in service settings
  48. British Association of Aesthetic Plastic SurgeonsPost-operative recovery timelines
  49. NHSRecovering from an operation
  50. Royal College of Surgeons of EnglandRecovering from surgery — patient information
  51. Equality and Human Rights CommissionReasonable adjustments for disabled people — guidance for service providers
  52. MencapCommunicating with people with a learning disability
  53. RNIBServing customers with sight loss
  54. RNIDCommunication tips for serving deaf customers
  55. ScopeMaking services accessible to disabled customers
  56. UK Parliament (legislation.gov.uk)Disability Discrimination Act 1995 (as amended, Northern Ireland)
  57. British Association of DermatologistsSkin cancer recognition guidance
  58. NHSMoles and the ABCDE checks for melanoma
  59. National Institute for Health and Care ExcellenceNG12 — Suspected cancer: recognition and referral
  60. American Academy of DermatologyPost-procedure healing guidance
  61. American Academy of DermatologyCosmetic procedure guidelines
  62. British Association of DermatologistsHerpes simplex management guidance
  63. NHSCold sores (herpes simplex) patient information
  64. General Medical Council (UK)Good Medical Practice
  65. UK legislationMental Capacity Act 2005
  66. Kidney Care UKLiving with kidney disease — patient information
  67. NHSChronic kidney disease
  68. NICEChronic kidney disease: assessment and management (NG203)
  69. British Association of DermatologistsPatch testing — patient information
  70. British Contact Dermatitis SocietyContact allergy guidance
  71. UK legislationThe Cosmetic Products Enforcement Regulations 2013
  72. British Thyroid FoundationThyroid disorders — patient information
  73. NHSUnderactive thyroid (hypothyroidism)
  74. NICE Clinical Knowledge SummariesHypothyroidism
  75. British Menopause SocietyMenopause — clinical guidance for patients
  76. NHSMenopause and perimenopause
  77. NICEMenopause: identification and management (NG23)
  78. The Menopause CharityMenopause symptoms and skin changes
  79. PubMed Central (peer-reviewed meta-analysis)Methotrexate and infection risk in rheumatoid arthritis — meta-analysis (Ibrahim et al.)
  80. The LancetBiologic treatment and serious infection risk in rheumatoid arthritis: systematic review and meta-analysis of 106 trials (Singh et al.)
  81. Lupus Foundation of AmericaRepairing skin damaged by lupus, and patient guidance on cosmetic procedures
  82. American Diabetes AssociationFoot care and diabetes
  83. Diabetes UKLooking after your feet with diabetes
  84. NHSDiabetes and foot problems
  85. NICENG28 — Type 2 diabetes in adults: management
  86. NHSIron deficiency anaemia
  87. American Heart AssociationDevices That May Interfere with ICDs and Pacemakers
  88. Leeds and York Partnership NHS Foundation TrustFacial Hair Reduction for Gender Dysphoria (patient information leaflet)
  89. NHS (Devon Sexual Health)Genital warts — patient information
  90. NHS (Sexual Health Sheffield)Genital warts — patient information
  91. NHS (West of Scotland Sexual Health Managed Clinical Network)Anogenital warts guidance
  92. NHS Scotland (Right Decisions)External anogenital warts
  93. American Pregnancy AssociationHair removal and pregnancy
  94. Age UKWellbeing, touch and personal care in later life
  95. British Geriatrics SocietyFit for Frailty — recognising and managing frailty
  96. NICENG56 — Multimorbidity: clinical assessment and management
  97. Hospice UKComplementary therapies and personal care in hospice settings
  98. Look Good Feel Better UKNail care, skin care and makeup during cancer treatment
  99. Macmillan Cancer SupportComplementary therapies and wellbeing
  100. Marie CurieComfort, dignity and personal care at the end of life
  101. JAMA DermatologyDelayed inflammatory reactions to hyaluronic acid fillers after COVID-19 vaccination — case reports
  102. American Academy of DermatologyKeloid management guidelines
  103. British Association of DermatologistsGuidance for skin of colour
  104. British Association of DermatologistsPsoriasis guidelines
  105. National Institute for Health and Care ExcellenceClinical Knowledge Summary — Psoriasis
  106. National Psoriasis FoundationKoebner phenomenon and trigger management
  107. American Academy of DermatologyIsotretinoin and cosmetic procedures — patient guidance
  108. British Association of DermatologistsIsotretinoin: patient information and prescribing guidance
  109. JAMA DermatologyASDS Guidelines Task Force: consensus recommendations regarding the safety of lasers, dermabrasion, chemical peels, energy devices and skin surgery during and after isotretinoin use (Waldman et al.)
  110. Peer-reviewed dermatology (PMC)Standard guidelines of care: procedures in patients on isotretinoin
  111. Alzheimer's SocietyDementia — information and support
  112. Dementia UKPersonal care and wellbeing in dementia
  113. NICEDementia: assessment, management and support (NG97)
  114. NHSOveractive thyroid (hyperthyroidism)
  115. NICE Clinical Knowledge SummariesHyperthyroidism
  116. MindPost-traumatic stress disorder (PTSD)
  117. NICEPost-traumatic stress disorder (NG116)
  118. PTSD UKPTSD — information and support
  119. Rape Crisis England & WalesSupport after sexual violence
  120. SAMHSA (US Substance Abuse and Mental Health Services Administration)SAMHSA's Concept of Trauma and Guidance for a Trauma-Informed Approach
  121. NHSPolycystic ovary syndrome (PCOS)
  122. NICEFertility problems: assessment and treatment (CG156)
  123. Verity (UK PCOS charity)PCOS and excess hair — patient information
  124. MS Society UKHeat sensitivity and MS
  125. MS Trust UKUhthoff's phenomenon
  126. NHSMultiple sclerosis
  127. National Multiple Sclerosis Society (US)Heat and temperature sensitivity
  128. NICEClinical Knowledge Summary — scleroderma
  129. Scleroderma & Raynaud's UK (SRUK)Living with scleroderma and Raynaud's — cold, heat and circulation
  130. NHSPostural (orthostatic) hypotension
  131. PubMed Central (peer-reviewed)Swedish massage and blood pressure
  132. NHSPregnancy skincare guidance
  133. UK Mastocytosis Support / Mastocytosis Society UKTriggers and everyday management of mast cell disease
  134. American Academy of DermatologyAtopic dermatitis guidelines
  135. National Eczema Society (UK)Trigger avoidance and treatment-flare guidance
  136. National Institute for Health and Care ExcellenceClinical Knowledge Summary — Eczema (atopic) in adults
  137. American Academy of DermatologyRosacea — triggers and treatment
  138. British Association of DermatologistsRosacea guidelines (Hampton et al., British Journal of Dermatology)
  139. National Rosacea SocietyRosacea trigger management and phenotype classification
  140. American Academy of DermatologyVitiligo — diagnosis and treatment
  141. British Association of DermatologistsVitiligo guidelines
  142. National Institute for Health and Care ExcellenceClinical Knowledge Summary — Vitiligo

All treatment categories

Written by · London-trained cosmetologist

Last updated